White matter lesions and temporal lobe atrophy related to incidence of both dementia and major depression in 70-year-olds followed over 10 years

European Journal of Neurology

Volumn 22, Issue 5, 2015, Pages 781-e50

  Gudmundsson, P ^a   Olesen, P J ^a   Simoni, M ^b   Pantoni, L ^b   Ostling S ^a   Kern, S ^a   Guo, X ^a   Skoog, I ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Computed tomography; Dementia; Depression; Longitudinal; Temporal lobe atrophy; White matter lesions

Indexed keywords

ANTIDEPRESSANT AGENT;

AGED; ARTICLE; BRAIN CORTEX ATROPHY; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DISEASE ASSOCIATION; DSM-5; DSM-III-R; FEMALE; FOLLOW UP; GERONTOPSYCHIATRY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TEMPORAL LOBE ATROPHY; WHITE MATTER LESION; ATROPHY; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; PATHOLOGY; RADIOGRAPHY; TEMPORAL LOBE; TIME FACTOR; WHITE MATTER;

AGED; ATROPHY; COMORBIDITY; DEMENTIA; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; TEMPORAL LOBE; TIME FACTORS; WHITE MATTER;

EID: 84926420905     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12651     Document Type: Article

References (51)

1. Palsson S, Skoog I. The epidemiology of affective disorders in the elderly: a review. Int Clin Psychopharmacol 1997; 12: S3-S13.
2. Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol 2011; 7: 323-331.
3. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 2013; 202: 329-335.
4. Huang CQ, Wang ZR, Li YH, Xie YZ, Liu QX. Cognitive function and risk for depression in old age: a meta-analysis of published literature. Int Psychogeriatr 2011; 23: 516-525.
5. Simoni M, Pantoni L, Pracucci G, et al. Prevalence of CT-detected cerebral abnormalities in an elderly Swedish population sample. Acta Neurol Scand 2008; 118: 260-267.
6. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013; 12: 483-497.
7. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004; 61: 1531-1534.
8. Kuller LH, Lopez OL, Newman A, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 2003; 22: 13-22.
9. Mortamais M, Reynes C, Brickman AM, et al. Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia. PLoS One 2013; 8: e56972.
10. Teodorczuk A, O'Brien JT, Firbank MJ, et al. White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry 2007; 191: 212-217.
11. Steffens DC, Krishnan KR, Crump C, Burke GL. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke 2002; 33: 1636-1644.
12. Firbank MJ, Teodorczuk A, van der Flier WM, et al. Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. Br J Psychiatry 2012; 201: 40-45.
13. Smith EE, Egorova S, Blacker D, et al. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 2008; 65: 94-100.
14. Korf ES, Wahlund LO, Visser PJ, Scheltens P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004; 63: 94-100.
15. Olesen PJ, Gustafson DR, Simoni M, et al. Temporal lobe atrophy and white matter lesions are related to major depression over 5 years in the elderly. Neuropsychopharmacology 2010; 35: 2638-2645.
16. Mueller SG, Mack WJ, Mungas D, et al. Influences of lobar gray matter and white matter lesion load on cognition and mood. Psychiatry Res 2010; 181: 90-96.
17. Skoog I. Psychiatric epidemiology of old age: the H70 study - the NAPE lecture 2003. Acta Psychiatr Scand 2004; 109: 4-18.
18. Bengtsson C, Blohme G, Hallberg L, et al. The study of women in Gothenburg 1968-1969 - a population study. General design, purpose and sampling results. Acta Med Scand 1973; 193: 311-318.
19. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
20. Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G. A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl 1978; 271: 5-27.
21. van der Laan NC, Schimmel A, Heeren TJ. The applicability and the inter-rater reliability of the Comprehensive Psychopathological Rating Scale in an elderly clinical population. Int J Geriatr Psychiatry 2005; 20: 35-40.
22. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(Suppl. 20): 22-33.
23. Skoog I, Nilsson L, Palmertz B, Andreasson LA, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med 1993; 328: 153-158.
24. Guo X, Waern M, Sjogren K, et al. Midlife respiratory function and incidence of Alzheimer's disease: a 29-year longitudinal study in women. Neurobiol Aging 2007; 28: 343-350.
25. Gottfries CG, Brane G, Gullberg B, Steen G. A new rating scale for dementia syndromes. Arch Gerontol Geriatr 1982; 1: 311-330.
26. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984; 141: 1356-1364.
27. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572.
28. Wancata J, Borjesson-Hanson A, Ostling S, Sjogren K, Skoog I. Diagnostic criteria influence dementia prevalence. Am J Geriatr Psychiatry 2007; 15: 1034-1045.
29. Jorm AF, Korten AE. Assessment of cognitive decline in the elderly by informant interview. Br J Psychiatry 1988; 152: 209-213.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association: Washington, DC, 1987.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, VA: American Psychiatric Association, 2013.
32. Skoog I, Nilsson L, Landahl S, Steen B. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int Psychogeriatr 1993; 5: 33-48.
33. Skoog I, Palmertz B, Andreasson LA. The prevalence of white-matter lesions on computed tomography of the brain in demented and nondemented 85-year-olds. J Geriatr Psychiatry Neurol 1994; 7: 169-175.
34. Gustafson D, Lissner L, Bengtsson C, Bjorkelund C, Skoog I. A 24-year follow-up of body mass index and cerebral atrophy. Neurology 2004; 63: 1876-1881.
35. de Leon MJ, Ferris SH, George AE, Reisberg B, Kricheff II, Gershon S. Computed tomography evaluations of brain-behavior relationships in senile dementia of the Alzheimer's type. Neurobiol Aging 1980; 1: 69-79.
36. Butters MA, Young JB, Lopez O, et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci 2008; 10: 345-357.
37. Gudmundsson P, Skoog I, Waern M, et al. The relationship between cerebrospinal fluid biomarkers and depression in elderly women. Am J Geriatr Psychiatry 2007; 15: 832-838.
38. Gustafson DR, Skoog I, Rosengren L, Zetterberg H, Blennow K. Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women. J Neurol Neurosurg Psychiatry 2007; 78: 461-464.
39. Skoog I, Davidsson P, Aevarsson O, Vanderstichele H, Vanmechelen E, Blennow K. Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds. Dement Geriatr Cogn Disord 2003; 15: 169-176.
40. Gudmundsson P, Skoog I, Waern M, et al. Is there a CSF biomarker profile related to depression in elderly women? Psychiatry Res 2010; 176: 174-178.
41. Greenwald BS, Kramer-Ginsberg E, Krishnan KR, Ashtari M, Auerbach C, Patel M. Neuroanatomic localization of magnetic resonance imaging signal hyperintensities in geriatric depression. Stroke 1998; 29: 613-617.
42. Thompson PM, Hayashi KM, de Zubicaray G, et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 2003; 23: 994-1005.
43. Rabins PV, Pearlson GD, Aylward E, Kumar AJ, Dowell K. Cortical magnetic resonance imaging changes in elderly inpatients with major depression. Am J Psychiatry 1991; 148: 617-620.
44. Palsson S, Larsson L, Tengelin E, et al. The prevalence of depression in relation to cerebral atrophy and cognitive performance in 70- and 74-year-old women in Gothenburg. The Women's Health Study. Psychol Med 2001; 31: 39-49.
45. Olesen PJ, Guo X, Gustafson D, et al. A population-based study on the influence of brain atrophy on 20-year survival after age 85. Neurology 2011; 76: 879-886.
46. Kumar A, Bilker W, Jin Z, Udupa J. Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression. Neuropsychopharmacology 2000; 22: 264-274.
47. Jang JW, Kim S, Na HY, et al. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease. Eur Neurol 2013; 69: 229-235.
48. Jokinen H, Lipsanen J, Schmidt R, et al. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology 2012; 78: 1785-1792.
49. Liebetrau M, Steen B, Skoog I. Depression as a risk factor for the incidence of first-ever stroke in 85-year-olds. Stroke 2008; 39: 1960-1965.
50. De la Monte S. Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol 1989; 25: 450-459.
51. Frisoni GB. Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools. J Neurol Neurosurg Psychiatr 2001; 70: 711-718.